Navigation Links
MBG Alert HSV 1, 2 Ensemble ASR*

ProductsMBG Alert HSV 1, 2 Ensemble ASR*
Company Nanogen, Inc.
Item MBG Alert HSV 1, 2 Ensemble ASR*
Features Inquire
DescriptionNanogen offers HSV 1,2 ASR* reagents for the detection of both HSV 1 and HSV 2 oligonucleotide sequences. These reagents do not differentiate between the two HSV sequences. The reagents are sold separately and laboratories may use them to create homebrew tests.

MGB Alert HSV 1,2 Primer Mix, 48 rxn
The MGB Alert HSV 1,2 Primer Mix consists of a ready to use 20x formulation for amplifying a region of the glycoprotein D region in HSV 1,2. It is biplexed with an Internal Control 2 primer pair and designed for use with the MGB Alert HSV 1,2 Probe Mix.

MGB Alert HSV 1,2 Probe Mix, 48 rxn
The MGB Alert HSV 1,2 Probe Mix consists of a FAM labeled probe in a ready to use 20x formulation for detecting a region of the glycoprotein D region in HSV 1,2. It is biplexed with an Internal Control 2 probe and designed for use with the MGB Alert HSV 1,2 Primer Mix.

MGB Alert HSV Positive Control, 100L
The MGB Alert Positive Control contains double stranded DNA template molecules that can be used as HSV1 and HSV 2 positive controls. It consists of a ready to use formulation with a concentration of 107 copies/L and is designed for use with MGB Alert HSV detection reagents.

MGB Alert Detection Reagents provide molecular labs a more advanced alternative for real-time PCR based assays. By using our MGB technology, combined with post-PCR dissociation melt curve analysis, Nanogen is able to provide molecular labs with powerful tools for detecting nucleic acid sequences of specific organisms or genetic mutations associated with disease, as well as enabling labs to probe molecular sequences that may not be accessible with other technologies.

MGB Alert Detection Reagents for specific analytes can be optimized for use with universal cycling parameters, most commercially available instruments, and supporting reagent systems. This facilitates easier implementation without additional capital investment for labs already set-up for real-time PCR.

The MGB Alert line includes ASRs for the detection of various pathogens including sequences associated with BK virus, Enterovirus, VZV, and other.
*Analyte Specific Reagents (ASR). Analytical and performance characteristics are not established
Product Page Link: http://www.nanogen.com/products/hsv_1_2/
InfoNanogen, Inc.
For information on ordering our products, please visit http://www.nanogen.com/contact/orderinfo/
For general information, please visit www.nanogen.com

Related medicine products :

1. BacT/Alert 3D Select
2. BacT/Alert 3D Select Link
3. BacT/Alert 3D Signature
4. RoamAlert Eco
5. RoamAlert Integrity Plus
6. RoamAlert Integrity
7. ProtecPoint Exit Alerting System
8. MGB Alert BK Virus ASR*
9. MGB Alert Chlamydia pneumoniae ASR*
10. MGB Alert CMV ASR*
11. MGB Alert HSV 1, 2 Typer ASR*
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products:
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... businesses nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach on solutions ... it should begin with the employer and employees getting together for meaningful group ...
(Date:8/28/2015)... ... ... Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back pain and associated ... pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received his Bachelor of ... earn his title of Doctor of Chiropractic from the Palmer College of Chiropractic and ...
(Date:8/28/2015)... ... ... Mendon, IL, home of the Adams County Fairgrounds, was treated once again to ... In its second year, the “Music With A Mission” benefit concert was held there ... “Music With A Mission” is to raise money to help fund music education programs ...
(Date:8/28/2015)... , ... August 28, 2015 , ... The newest therapy ... be available for general use any time soon, according to educational website Surviving Mesothelioma. ... therapy that received orphan drug designation for mesothelioma last week from the FDA, will ...
(Date:8/28/2015)... ... August 28, 2015 , ... External Counterpulsation, also known as ... is now selling External Counterpulsation (EECP or ECP) machines with a full clinic licence ... been in business since 2007 helping people prevent and reverse heart disease ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2
... associated with age, might affect women with diabetes or ... recent study .// ,The study shows elderly ... and are at an increased risk for developing cognitive ... women with pre-diabetes or diabetes was increased nearly two-fold. ...
... say that they have now found out that long-term use ... of cancer.// ,The trial results of the longest follow-up ... show cardiovascular death was reduced by 17 percent and coronary ... drug simvastatin, also known as Zocor, for 10 years compared ...
... 600 babies in the United States is born with an isolated ... cleft only // and no other birth defects. ,Researchers say ... if a couple will have a child born with a cleft ... According to researchers isolated clefts happen during early fetal development. ...
... a degenerative joint disease and one of the oldest ... the joint’s cartilage breaks down and the bones rub ... ,An international, multi-center study shows an effective treatment ... as Prexige. The drug was found to reduces gastric ...
... public places can improve the overall likelihood someone will ... AEDs -- devices capable of shocking the heart back ... 1,000 shopping malls, apartment complexes, and other public places ... volunteers in these communities were then trained in either ...
... recent study researchers say cancer patients who receive treatment have ... new study shows many doctors are not taking the necessary ... more than 100 oncologists to determine if the doctors were ... preventative measures used by the physicians. About 40 percent of ...
Cached Medicine News:
(Date:8/28/2015)... Research and Markets ... the "Investigation Report on China,s Latanoprost Market, ... Developed by Pharmacia & Upjohn in 1995, latanoprost ... reduces intraocular pressure. As the first pressure- lowering ... name of Xalatan) entered China ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015  Perrigo Company ... that it has completed the acquisition of leading OTC ... at €200 million. The transaction is a clear demonstration ... the Company,s leading European distribution network spanning 36 countries.  ... Joseph C. Papa commented, "We are excited to ...
(Date:8/28/2015)... y LONDRES, 28 de agosto de 2015 ... anunció hoy su participación en el  Congreso de ... soluciones cardiológicas más recientes y novedosas, entre ellas ... conectan a las personas y la tecnología con ... a diagnosticar, guiar los tratamientos y permitir atención ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5